SCHEMBL30966103

SCHEMBL30966103

COC(=O)c1cc(OCCOc2cc(CBr)c(C(=O)OC)cc2Cl)ccc1CBr

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.40
▸ S1PR4 O95977 1/20 0.39
▸ SCN9A Q15858 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ MAOB P27338 2/20 0.37
▸ MAOA P21397 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27433963 1.00 MAPT (0.40) MAPTS1PR4SCN9ATDP1L3MBTL1
SCHEMBL30966104 0.85 MAPT (0.46) MAPTTDP1L3MBTL1RAB9AMAOB
SCHEMBL27433301 0.85 MAPT (0.46) MAPTTDP1L3MBTL1RAB9AMAOB
SCHEMBL27434442 0.83 MAPT (0.38) MAPTS1PR4TDP1L3MBTL1HTT
SCHEMBL30966109 0.83 MAPT (0.38) MAPTS1PR4TDP1L3MBTL1HTT
SCHEMBL30966089 0.81 MAOB (0.43) MAPTL3MBTL1RAB9AMAOBMAOA
SCHEMBL27433526 0.81 MAPT (0.42) MAPTTDP1L3MBTL1RAB9AMAOB
SCHEMBL27433446 0.81 MAOB (0.43) MAPTL3MBTL1RAB9AMAOBMAOA
SCHEMBL27141409 0.81 PLA2G2A (0.46) MAPTL3MBTL1MAOBMAOAKDM4E
SCHEMBL29127993 0.79 GAA (0.53) MAPTHTTRAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638460-A1 BENZIMIDAZOLE DERIVATIVES FOR THE MODULATION OF STING Aculeus Therapeutics Pty Ltd (AU) 2025-10-29 — — EP disclosed
WO-2024130341-A1 BENZIMIDAZOLE DERIVATIVES FOR THE MODULATION OF STING Aculeus Therapeutics Pty Ltd (AU) 2024-06-27 — — WO disclosed
Send feedback